Dozens of states, including New York, are suing to block the sale of 23andMe personal genetic data without customer consent.

Twenty-seven states and Washington, D.C., filed the lawsuit in bankruptcy court on Monday.

State Attorney General Letitia James said biological samples, DNA data, health-related traits, and medical records are too sensitive to be sold without each person’s express, informed consent.

She goes on to say customers should have the right to control such deeply personal information, and it cannot be sold like ordinary property.

Regeneron Pharmaceuticals entered an agreement last month to buy the company for $256 million.